Shares in Bayer fell 5% on Monday after a Philadelphia jury told the German pharmaceutical company to pay $2.25 billion to a man who says he developed cancer due to using its Roundup branded weedkiller. A jury at Philadelphia Court of Common Pleas awarded John McKivision $2 billion in punitive damages and an additional $250 million in compensatory damages in ruling the claimant developed non-Hodgkin’s lymphoma as a result of exposure to Bayer’s glyphosate-based weedkiller.
Shares in Bayer
BAYA,
-3.09%
fell 5% on Monday having lost 46% of their value over the past 12 months. Bayer has faced around 165,000 lawsuits from Roundup customers who claim they developed cancer due to using the glyphosate-based weedkiller, which was first developed by Monsanto in the 1970s, prior to the U.S. company’s acquisition by Bayer for $66 billion in 2018. “The jury’s punitive damages award sends a clear message that this multi-national corporation needs top to bottom change,” McKivision’s attorneys Tom Kline and Jason Itkin told Reuters. Lawyers acting for McKivision were contacted by MarketWatch for comment. In a statement, Bayer vowed to appeal the Philadelphia court’s decision. The German company has repeatedly denied that exposure to its glyphosate-based weedkiller is responsible for its customers developing illnesses. “We …
Article Attribution | Read More at Article Source
Shares in Bayer
BAYA,
-3.09%
fell 5% on Monday having lost 46% of their value over the past 12 months. Bayer has faced around 165,000 lawsuits from Roundup customers who claim they developed cancer due to using the glyphosate-based weedkiller, which was first developed by Monsanto in the 1970s, prior to the U.S. company’s acquisition by Bayer for $66 billion in 2018. “The jury’s punitive damages award sends a clear message that this multi-national corporation needs top to bottom change,” McKivision’s attorneys Tom Kline and Jason Itkin told Reuters. Lawyers acting for McKivision were contacted by MarketWatch for comment. In a statement, Bayer vowed to appeal the Philadelphia court’s decision. The German company has repeatedly denied that exposure to its glyphosate-based weedkiller is responsible for its customers developing illnesses. “We …nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]